This study aimed to develop a new riskadjustment method to assess acute myocardial infarction (AMI) in-hospital mortality. Risk-adjustment was based on variables obtained from administrative data from Japanese hospitals, and included factors such as age, gender, primary diagnosis and co-morbidity. The infarct location was determined using the criteria of the International Classification of Diseases (10th version). Potential comorbidity risk factors for mortality were selected based on previous studies and their critical influence analysed to identify major co-morbidities. The remaining minor co-morbidities were then divided into two groups based on their medical implications. The major co-morbidities included shock, pneumonia, cancer and chronic renal failure. The two minor co-morbidity groups also demonstrated a substantial impact on mortality. The model was then used to assess clinical performance in the participating hospitals. Our model reliably employed the available data for the risk-adjustment of AMI mortality and provides a new approach to evaluating clinical performance.
Introduction
When comparing the management, cost and patient outcomes for different institutions, it is necessary to adjust for patient risk. In the USA and Europe, detailed clinical data have been analysed to develop risk-adjustment models. 1 -5 As an alternative, riskadjustment models developed using administrative data 2,4,6 -10 without any detailed clinical information have also been widely adopted. Administrative data have the advantage of being relatively easy to collect since they are continuously generated through routine workflow.
Risk-adjustment models based on detailed clinical data or administrative data are not currently available in Japan. Clinical information systems are in an early developmental stage, and neither detailed clinical data nor administrative data are readily available from medical record systems. Studies are restricted, therefore, to K Hayashida, Y Imanaka, M Sekimoto et al. Evaluation of acute myocardial infarction in-hospital mortality the limited administrative data that are voluntarily submitted. It is critical to develop Japanese risk-adjustment models that are reliable and can be generated from a small sample size with a low number of variables.
The purpose of this study was to develop a risk-adjustment model for acute myocardial infarction (AMI) in-hospital mortality using a new approach based on accumulated administrative data, and to use this model to identify excellent and poor clinical performance among hospitals.
Patients and methods

DATA SOURCES AND SELECTION
Data were obtained from the Quality Indicator Project (QIP), which collates data from 11 leading private teaching hospitals in Japan. Available information for each patient included a hospital code, age, gender, admission and discharge dates, admission route, outcome, primary diagnosis, up to four co-morbidities, up to four complications and an operation code. The following patient selection criteria were used for the study: (i) primary diagnosis of AMI (code I21 in the International Classification of Diseases, 10th version); (ii) acute admission route; and (iii) a discharge date between 1 April 2001 and 31 March 2003; only patients from hospitals with more than 100 registered cases matching these criteria were included.
This study was approved by the Institutional Review Board of the Faculty of Medicine at the Graduate School of Medicine of Kyoto University, Japan.
MODEL DEVELOPMENT
A model for predicting AMI mortality was developed using primary diagnoses and comorbidities. The reliability and explanatory ability of the proposed model was tested by measuring the area under the receiver operating characteristics (ROC) curve.
The new approach included determining the infarct location of the primary diagnosis, extrapolating co-morbidities with a critical impact on mortality (major co-morbidities), and creating two groups from the other comorbidities based on medical implications (minor co-morbidities). The following steps were performed to select the appropriate comorbidities.
Potential co-morbidity risk factors for mortality were selected from the administrative data based on previous studies (Tu co-morbidity index 11 , Dartmouth-Manitoba adaptation of the Charlson co-morbidity index 12 -14 , diagnosisrelated groups 15 ) and univariate analyses of these co-morbidities with hospital deaths were determined using χ 2 tests. A P-value < 0.2 was considered to be statistically significant in advance of subsequent multivariate logistic regression analysis and was set at this level in order not to miss potentially important risk factor candidates in the preliminary analysis.
The most powerful predictors of hospital deaths were then identified based on both clinical and statistical significance using a backward stepwise logistic regression analysis of the co-morbidities, in addition to age, gender and infarct location; these were the major co-morbidities.
Finally, the minor co-morbidities (i.e. those co-morbidities remaining after removal of the major co-morbidities) were classified into two groups based on their medical implications: co-morbidities directly associated with AMI (mostly related to the decline of heart pumping function) and comorbidities not directly associated with AMI. Dichotomous variables were created for each of these two groups and included in the prediction model. Multivariate logistic regression analysis was performed and the final prediction model generated. To K Hayashida, Y Imanaka, M Sekimoto et al.
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measure the model's calibration, we performed the Hosmer-Lemeshow test. 16 All statistical analyses were performed using the SPSS ® statistical package version 11.0 (SPSS Inc., Chicago, IL, USA).
EVALUATION OF HOSPITALS
The expected and risk-adjusted mortality rates for each hospital were calculated to evaluate and compare clinical performance and treatment outcomes. The expected mortality rate was calculated by adding the predicted probabilities of death for each of the hospital's patients and then dividing by the number of patients. The risk-adjusted mortality rate was calculated by dividing each hospital's observed mortality rate by its expected mortality rate, and then multiplying this by the average of all the cases in the dataset.
Results
PATIENT CHARACTERISTICS
Overall, data from a total of 1437 patients were selected from six hospitals, with a mortality rate of 10.2%. The mean age (±SD) was 69.7 ± 12.1 years, and 69.9% of the patients were male. Most patients (78.3%) had undergone percutaneous coronary intervention (PCI). Overall, 77.7% of patients underwent PCI alone, 0.6% underwent both PCI and coronary artery bypass graft (CABG), 2.9% underwent CABG alone, and 18.8% had no surgical intervention.
MODEL DEVELOPMENT AND VALIDATION
A total of 12 co-morbidities were selected for the prediction model, as shown in Table 1 . In addition to age and gender, infarct location and the co-morbidities of shock, pneumonia, cancer and chronic renal failure were adopted in the final prediction model on the basis of logistic regression analysis. Table 2 shows the logistic regression coefficients and odds ratios with 95% confidence intervals for predicting in-hospital mortality after AMI.
The variable with the highest odds ratio was shock, followed by age. Infarct location 
Co-morbidities and infarct location
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and gender were also critical factors. With respect to the minor co-morbidity groups, the group of co-morbidities associated with AMI had a moderate, statistically significant impact on mortality. In contrast, the group of co-morbidities not directly associated with AMI had an impact on mortality but this was not statistically significant.
The area under the ROC curve of our final model was 0.80 (95% confidence interval 0.77 -0.84), which is relatively high.
EVALUATION OF HOSPITALS
The observed mortality rate, the riskadjusted mortality rate and 95% confidence interval of the expected mortality rate for each hospital are shown in Fig. 1 . When the expected and observed mortality rates were compared, three of the six hospitals examined demonstrated a mortality rate within the 95% confidence interval of the expected mortality. In one hospital the observed mortality was below the 95% confidence interval of the expected mortality, while in two hospitals it was above the 95% confidence interval.
When comparing the hospitals, the rank order differed for the risk-adjusted mortality rate and the observed, unadjusted mortality rate. Importantly, there was no relationship between the number of cases at a hospital and the treatment outcome observed there. The hospital with the largest number of cases demonstrated a positive clinical performance, while the hospital with the second largest number of cases did not. 
Discussion
In the present study, a risk-adjustment model was developed using accumulated administrative data from six hospitals in Japan. This model was used to assess AMI mortality rates and to evaluate clinical performance at these hospitals. The resulting risk-adjustment model demonstrates a number of advantages over existing methods. The new model shows the feasibility of developing a riskadjustment model with a small sample size and a low number of variables (the database used only four co-morbidity data spaces). It has the capacity to allow new risk factors to be adopted to obtain maximal information from a small number of variables. Finally, it is useful for evaluating hospitals in countries where a large database is not available. Until recently in Japan, there was no database linked to the reimbursement system, and inclusion in the existing database was voluntary. It was, therefore, crucial to develop an appropriate risk-adjustment model that used a small amount of information efficiently. Our risk-adjustment model is practical for using limited data to assess mortality rates and clinical performance. Despite the small number of variables used in our model, its performance was approximately equal or superior to models developed in previous studies. The area under the ROC curve for our model was 0.80, which is superior to other studies using administrative data, 4,6 -10 except for one, 2 and equally as proficient as studies using detailed clinical data. 1 -5 This was possible because of our novel strategy to incorporate new variables by linking minor co-morbidities based on their medical implications. The performance of our model was reliable and our methodology was conceptually unique.
When comparing risk-adjusted mortality rates across the hospitals studied, the observed mortality rate was below the 95% confidence interval of the expected mortality in one case and above the 95% confidence interval in two cases. This perhaps suggests that one hospital had a particularly high clinical performance and two had low clinical performances. The number of cases treated at a hospital was not predictive of outcome and there are conflicting reports as to whether there is a relationship between the number of cases at a hospital and treatment outcome. Some studies have shown a relationship between the two 17 -20 , while others 21 -23 have not; the present study supports the latter position.
Some limitations must be considered when interpreting the results of this study. First, the hospitals selected for this study are not representative of all hospitals in Japan: the hospitals taking part in QIP are leading private teaching hospitals that treat large numbers of patients. The Japanese government has recently collected a large amount of data from many hospitals due to the introduction of a new reimbursement system, and further studies of new data will become possible. Secondly, because previous studies 24, 25 have suggested a difference between administrative and clinical data, it is not certain that a risk-adjustment model can be developed solely from administrative data. In the present study it was impossible to compare these two data sources as clinical data were not available.
In conclusion, in the present study a riskadjustment model was developed based on AMI mortality rates in Japanese hospitals using administrative data. Our proposed model offers a new approach to evaluating the clinical performance of hospitals. It is essential for governments, insurers, health care providers and patients that adequate riskadjustment models be developed easily and efficiently. In this regard, our risk-adjustment model works well with presently available data and has a high capacity for adjustment. This risk-adjustment model was developed using the scarce data available in Japan, but scarcity of hospital data is not unique and other countries with similar circumstances could adopt our innovative framework.
